Cognitive mediators of treatment outcomes in pediatric functional abdominal pain

Rona L Levy1, Shelby L Langer, Joan M Romano

  • 1*School of Social Work †Department of Psychiatry & Behavioral Sciences, University of Washington #Department of Gastroenterology, Seattle Children's Hospital, Seattle, WA ‡Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA §Department of Pediatrics, Vanderbilt University, Nashville, TN ∥Department of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC ¶Mt. Sinai School of Medicine, New York, NY.

Insights

Cognitive-behavioral therapy for childhood abdominal pain works by reducing parent threat perception and child catastrophic thinking. These changes in thinking mediate symptom improvement, highlighting cognitive processes as key mechanisms for treatment success.

Area of Science:

  • Pediatric Psychology
  • Clinical Psychology
  • Gastroenterology

Background:

  • Cognitive-behavioral (CB) interventions show promise for pediatric health conditions.
  • Mechanisms underlying CB intervention effectiveness in children are not well understood.
  • Idiopathic childhood abdominal pain is a common condition requiring effective treatments.

Purpose of the Study:

  • To identify mediating mechanisms of a brief CB intervention for childhood abdominal pain.
  • To examine whether changes in targeted process variables mediate treatment outcomes.
  • To investigate the role of parental responses and child cognitions in treatment efficacy.

Main Methods:

  • A randomized controlled trial with 200 children with functional abdominal pain.
  • Comparison of a 3-session social learning and CB treatment versus an educational control.
  • Assessment of outcomes at 3-, 6-, and 12-month follow-ups using multiple mediation analyses.

Main Results:

  • Reductions in parents' perceived threat mediated improvements in child GI symptom severity and pain.
  • Decreased catastrophic cognitions in children mediated reduced child-reported GI symptom severity.
  • Parental solicitousness changes did not mediate treatment outcomes.

Conclusions:

  • The effectiveness of CB interventions for childhood abdominal pain is partly mediated by reductions in maladaptive parent and child cognitions.
  • Targeting parental threat perception and child catastrophic thinking are crucial components of successful interventions.
  • Understanding these mechanisms can inform the development of more targeted and effective treatments.
Abstract

Related Concept Videos

Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
989
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K